Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ANTARES PHARMA INC | 9,080,445 | reported | 23 Jun 2015 | tx 9−499,895 |
| SALIX PHARMACEUTICALS LTD | 3,800,750 | reported | 29 Jul 2009 | tx 6+128,034−229,578 |
| MEDICINES CO /DE | 3,292,325 | reported | 01 Apr 2011 | tx 14−279,915 |
| XENOPORT INC | 2,746,650 | reported | 19 Feb 2016 | tx 2+20,973 |
| DYNAVAX TECHNOLOGIES CORP | 2,035,137 | reported | 04 Oct 2006 | tx 28+1,212,694 |
| NxStage Medical, Inc. | 1,292,874 | reported | 15 Dec 2009 | tx 10−102,388 |
| Auspex Pharmaceuticals, Inc. | 849,426 | reported | 28 Jan 2015 | tx 5+1,500,000 |
| RIGEL PHARMACEUTICALS INC | 762,700 | reported | 26 May 2011 | tx 4+650,000 |
| INSPIRE PHARMACEUTICALS INC | 657,724 | reported | 11 Apr 2006 | tx 4+100,000 |
| AveXis, Inc. | 88,000 | reported | 17 Feb 2016 | tx 16+2,472,694−1,486,383 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2016 | PURCHASE | XENOPORT INC | 9,228 | 3.99 USD | |
| 19 Feb 2016 | PURCHASE | XENOPORT INC | 11,745 | 3.99 USD | |
| 17 Feb 2016 | PURCHASE | AveXis, Inc. | 163,702 | 20.00 USD | |
| 17 Feb 2016 | PURCHASE | AveXis, Inc. | 88,000 | 20.00 USD | |
| 17 Feb 2016 | PURCHASE | AveXis, Inc. | 112,000 | 20.00 USD | |
| 03 Sept 2015 | PURCHASE | AveXis, Inc. | 131,911 | 18.48 USD | |
| 17 Feb 2016 | CONVERSION | AveXis, Inc. | 67,448 | — | |
| 17 Feb 2016 | CONVERSION | AveXis, Inc. | 1,182,941 | — | |
| 03 Sept 2015 | PURCHASE | AveXis, Inc. | 131,911 | 18.48 USD | |
| 17 Feb 2016 | CONVERSION | AveXis, Inc. | 117,996 | — | |
| 17 Feb 2016 | CONVERSION | AveXis, Inc. | 117,998 | — | |
| 17 Feb 2016 | PURCHASE | AveXis, Inc. | 122,793 | 20.00 USD | |
| 17 Feb 2016 | CONVERSION | AveXis, Inc. | 67,448 | — | deriv |
| 03 Sept 2015 | PURCHASE | AveXis, Inc. | 117,998 | 21.01 USD | deriv |
| 17 Feb 2016 | CONVERSION | AveXis, Inc. | 117,996 | — | deriv |
| 03 Sept 2015 | PURCHASE | AveXis, Inc. | 117,996 | 21.01 USD | deriv |
| 17 Feb 2016 | CONVERSION | AveXis, Inc. | 117,998 | — | deriv |
| 17 Feb 2016 | CONVERSION | AveXis, Inc. | 1,182,941 | — | deriv |
| 19 Jun 2015 | SALE | ANTARES PHARMA INC | 66,842 | 2.41 USD | |
| 19 Jun 2015 | SALE | ANTARES PHARMA INC | 52,518 | 2.41 USD | |
| 23 Jun 2015 | SALE | ANTARES PHARMA INC | 67,475 | 2.35 USD | |
| 22 Jun 2015 | SALE | ANTARES PHARMA INC | 83,338 | 2.41 USD | |
| 22 Jun 2015 | SALE | ANTARES PHARMA INC | 65,479 | 2.41 USD | |
| 23 Jun 2015 | SALE | ANTARES PHARMA INC | 28,510 | 2.35 USD | |
| 23 Jun 2015 | SALE | ANTARES PHARMA INC | 85,877 | 2.35 USD |
2 purchases reported after at least 12 months of silence — most recent on 28 Jan 2015.